share_log

Recce Pharmaceuticals Ltd: R327 Efficacy against WHO Priority Pathogen Acinetobacter B

Recce Pharmaceuticals Ltd: R327 Efficacy against WHO Priority Pathogen Acinetobacter B

Recce Pharmaceuticals Ltd:R327對世界衛生組織優先級病原體Acinetobacter B有效
07/07 19:53
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息